Wild-type RAS Metastatic Colorectal Cancer

DBCOND0060255Gastrointestinal Tract Disorders

Wild-type RAS Metastatic Colorectal Cancer is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
RAS Wild Type mCRC
Classified under
Indicated drugs

What you can answer from here — as of November 02, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Wild-type RAS Metastatic Colorectal Cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In